Medicare and preexisting condition waiting periods
Due to the Affordable Care Act (ACA), Original Medicare (parts A and B), Medicare Advantage (Part C), and Part D drug plans cannot impose waiting periods for preexisting conditions or deny coverage based on such conditions.
However, Medicare supplement (Medigap) plans are not subject to the ACA. For this reason, people who wish to sign up for a Medigap plan should be aware of enrollment and waiting periods where preexisting conditions might be applicable. Medigap initial enrollment period
Private companies approved by Medicare offer Medigap plans, which are also called Medicare supplement plans. These plans cover costs that Original Medicare does not cover, such as deductibles, coinsurance, and copayments.
Since Medigap plans do not provide direct medical coverage and do not meet the ACA's minimum essential coverage requirements, insurers can deny coverage due to preexisting conditions. However, other federal laws impose certain restrictions, one of which applies during the initial enrollment period.
When a person turns 65 and enrolls in Medicare Part B, they enter a six-month Medigap open enrollment period. During this time, they can choose any Medigap policy without undergoing medical underwriting. Insurers cannot deny them coverage based on preexisting conditions, allowing the person to select the plan that best fits their needs.
If a person misses this enrollment period, they may face higher costs or experience coverage denial. Additionally, those under 65 who qualify for Medicare due to a disability might have to wait until they reach 65 before Medigap insurers must legally offer them coverage. » Learn moreDoes Medicare cover preexisting conditions?
Insurance companies can refuse to enroll a person in a Medigap plan based on preexisting conditions if the person applies outside the initial 6-month enrollment window.
However, exceptions exist in which a person can get protection from coverage denial even after this period ends. These exceptions, called 'guaranteed issue rights,' apply in the following specific circumstances:
A Medicare Advantage Plan either changes, becomes unavailable in the person's area, or the person moves outside its service zone.
A person with Original Medicare and an employer or union plan that offers coverage after Medicare, including the Consolidated Omnibus Budget Reconciliation Act (COBRA), loses that coverage.
A person with Original Medicare and a Medicare SELECT policy moves out of the policy's service area.
A person who initially joined a Medicare Advantage Plan or Programs of All-Inclusive Care for the Elderly (PACE) when they first became eligible for Medicare decides to switch to Original Medicare within the first year.
A person who switched to a Medicare Advantage Plan (or Medicare SELECT) within the past year now wants to switch again.
A person's Medigap insurance provider goes bankrupt or cancels a person's policy through no fault.
A person changes or cancels their Medicare Advantage plan or Medigap policy due to a violation or misleading information from the provider.
Additionally, some states may have additional 'guaranteed rights' beyond what federal regulations require. » Learn more:What to know about Guaranteed Issue in Medicare
Ten Medigap plans offer different levels of coverage. A person who has held their current Medigap policy for more than 6 months and wants to switch to the same Medigap plan offered by another insurance plan cannot experience coverage denial based on preexisting conditions, nor do they have to wait for coverage.
But if a person wants to switch between different Medigap plans, they may have to wait 6 months for coverage. This is known as the preexisting condition waiting period.
However, their new insurer should account for the period when the person has had coverage from their existing Medigap plan. For example, if a person has had 2 months of coverage before switching, their new policy should only impose an additional 4-month wait. Medicare Advantage trial period
Medicare Advantage (Part C) plans must offer coverage equivalent to Original Medicare (parts A and B). According to the ACA, insurers providing Part C plans cannot deny coverage based on preexisting conditions.
However, since a person can only have Medigap for Original Medicare expenses, they must discontinue their Medigap plan if they choose a Part C plan.
For this reason, Medicare grants a 12-month trial period to allow a person to test a Part C plan without losing their Medigap coverage. The person may leave the Part C plan and return to Original Medicare within this period. In that case, they can rejoin their previous Medigap plan or select a new one without medical underwriting.
Original Medicare (parts A and B), Medicare Advantage (Part C), and Part D prescription plans have no preexisting conditions waiting periods. This means these plans cannot deny coverage because of preexisting conditions.
However, specific enrollment and waiting periods for preexisting conditions might apply to a Medicare supplement (Medigap) plan. These include a 6-month initial enrollment period, guaranteed issue rights, and a 12-month trial period to test a Part C plan.
The information on this website may assist you in making personal decisions about insurance, but it is not intended to provide advice regarding the purchase or use of any insurance or insurance products. Healthline Media does not transact the business of insurance in any manner and is not licensed as an insurance company or producer in any U.S. jurisdiction. Healthline Media does not recommend or endorse any third parties that may transact the business of insurance.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Independent
20 minutes ago
- The Independent
Trump will host Kennedy Center Honors in presidential first. Here's who's on the honorees list
Ten years after his career as a television star ended when he launched his first campaign for the presidency, President Donald Trump is returning to his presenter roots as host of this year's Kennedy Center Honors award ceremony this December. The president, who appointed himself head of the Kennedy Center shortly after taking office, made the announcement himself at a press conference to unveil this year's slate of honorees. He claimed the Kennedy Center board had requested that he serve as the emcee of this year's show, stepping into shoes once filled by the late CBS News anchor Walter Cronkite from 1981 to 2002, then by Ambassador Caroline Kennedy — the daughter of President John F. Kennedy, for whom the arts center is named — from 2003 to 2012. More recently, the award ceremony was hosted by Glenn Close, Stephen Colbert, Gloria Estefan, LL Cool J, and David Letterman.
The Independent
20 minutes ago
- The Independent
NASA's nuclear gamble on the moon faces growing skepticism
Fast-tracking a NASA plan to build a nuclear reactor on the moon may sound dubious. Experts say that's because it is. 'The whole proposal is cock-eyed and runs against the sound management of a space program that is now being starved of money,' national security analyst, nuclear expert and author Joseph Cirincione told The Independent. Nuclear has been used in space since the 1960s. That's nothing new. The U.S. launched its first test reactor into orbit in 1965, and the former Soviet Union has sent up dozens more. NASA says that a new 100-kilowatt reactor could be used to power a future base at the lunar South Pole, and fuel prospective missions to Mars and beyond. Nuclear would help to fill gaps in solar energy that occur when that side of the moon is in darkness for two weeks. The majority of space experts have said that placing a reactor on the moon is possible, so, why is NASA's current plan 'cock-eyed?' The problem is the proposed timeline. Interim NASA Administrator Sean Duffy, who also serves as President Donald Trump's Secretary of Transportation, pushed to expedite the project, detailed in a memo this week. Duffy said the administration wanted to have a nuclear reactor ready to launch by 2030. Earlier this year, China and Russia announced a plan to build a nuclear reactor for a lunar base by 2035. 'The first country to do so could potentially declare a 'keep-out' zone which would significantly inhibit the United States from establishing a planned Artemis presence if not there first,' Duffy said. NASA first announced in 2021 that it would put a reactor on the moon 'within a decade.' In 2024, NASA then said that their target date for delivery a reactor to the Earth-based launchpad was the early 2030s. But, Cirincione says essentially no progress has been made. 'It was in the last Trump administration that NASA had put out a press release, they had a YouTube video, they had these announcements about how they're going to develop these small, modular nuclear reactors for use on the moon, and it was going to be ready by 2026,' said Cirincione, who is vice-chair of the Center for International Policy, a non-profit that advocates for a peaceful approach to foreign policy. 'Oh, really? So, where is it?' Ultimately, the expert believes a nuclear reactor on the moon could take up to 20 years to become a reality. NASA would need a working launch vehicle, a small and adaptable reactor, and the ability to land on the moon. Right now, the SpaceX Starship is the only vehicle option – but it has exploded during several of its test flights. NASA has been working with Boeing on a Space Launch System - the main competitor to Space X's Starship - but that program would be canceled under the Trump administration's proposed cuts which slash 24 percent from NASA's overall budget. Landing on the moon is no picnic, and attempts by Japanese space companies in 2023 and 2025 ended in crashes. There are also the scientific and technological advances needed for the nuclear reactors. The reactors must be able to withstand harsh conditions on the moon, including temperatures swings from 250 degrees Fahrenheit during the day to minus 400 degrees at night. 'Small modular nuclear reactors, it turns out, are always just around the corner – a corner you never get to turn,' Cirincione said. Many scientists and nuclear energy experts have shared in Cirincione's skepticism. Dr. Kathryn Huff, a former nuclear energy official at the U.S. Department of Energy, and professor at the University of Illinois at Urbana-Champaign, wrote in a Bluesky social media post that she's not 'bullish' on 'unrealistic timelines.' 'The 2030 target does not align well with recent budgetary trends…' she explained in a statement, shared by the university. 'Accelerating the FSP program could come at the expense of other critical priorities, including earth science, climate observation and space-based weather forecasting – all core elements of NASA's public-serving mission.' Dr. Alfredo Carpineti, an Italian astrophysicist, wrote in IFLScience this week that the proposal is 'unfeasible.' 'Even if we allow landing the nuclear reactor on December 31, 2030, the timing is really too short for something that must not have any faults if you want to operate it safely,' Carpineti wrote. Others were more optimistic about NASA's accelerated timeline. Sebastian Corbisiero, a senior program manager at Idaho National Laboratory who leads the Energy Department's space reactor program, told The Independent that a nuclear reactor on the moon is 'doable' by 2030. 'Nuclear reactor technology has been around for decades, so its well known,' he said. 'Some key differences with a space reactor is that it needs to fit on a rocket, so there are mass and volume requirements; and that the system needs to operate in vacuum – so components will need to be built to survive that environment.' Dr. Bhavya Lal, a former associate administrator for technology, policy, and strategy at NASA, and former aerospace executive Roger Myers, recently argued that it would be possible to have nuclear reactor on the moon by 2030, and it would take $3 billion to do so. 'It's possible, but it will require serious commitment,' Lal told The Independent. But even if plans are speeded up, Lal says there's no need to worry about the prospect of the moon blowing up. It's 'simply not grounded in science,' she said.
The Independent
20 minutes ago
- The Independent
AI could soon detect early voice box cancer from the sound of your voice
AI could soon be able to tell whether patients have cancer of the voice box using just a voice note, according to new research. Scientists recorded the voices of men with and without abormalities in their vocal folds - which can be an early sign of laryngeal cancer - and found differences in vocal qualities including pitch, volume, and clarity. They now say AI could be used to detect these 'vocal biomarkers', leading to earlier, less invasive diagnosis. Researchers at Oregon Health and Science University believe voice notes could now be used to train an AI tool that recognises vocal fold lesions. Using 12,523 voice recordings from 306 participants across North America, they found distinctive vocal differences in men suffering from laryngeal cancer, men with vocal fold lesions, and men with healthy vocal folds. However, researchers said similar hallmark differences were not detected in women. They are now hoping to collect more recordings of people with and without the distinctive vocal fold lesions to create a bigger dataset for tools to work from. In the UK, there are more than 2,000 new cases of laryngeal cancer each year. Symptoms can include a change in your voice, such as sounding hoarse, a high-pitched wheezing noise when you breathe, and a long-lasting cough. 'Here we show that with this dataset we could use vocal biomarkers to distinguish voices from patients with vocal fold lesions from those without such lesions,' said Dr Phillip Jenkins, the study's corresponding author said. 'To move from this study to an AI tool that recognises vocal fold lesions, we would train models using an even larger dataset of voice recordings, labeled by professionals. We then need to test the system to make sure it works equally well for women and men. 'Voice-based health tools are already being piloted. Building on our findings, I estimate that with larger datasets and clinical validation, similar tools to detect vocal fold lesions might enter pilot testing in the next couple of years," he predicted. It comes after research from US-based Klick Labs, which created an AI model capable of distinguishing whether a person has Type 2 diabetes from six to 10 seconds of voice audio. The study involved analysing 18,000 recordings in order to identify acoustic features that differentiated non diabetics from diabetics and reported an 89 per cent accuracy rating for women and 86 per cent for men. Jaycee Kaufman, a research scientist at Klick Labs, praised the future potential for AI-powered voice tools in healthcare, saying: 'Current methods of detection can require a lot of time, travel and cost. Voice technology has the potential to remove these barriers entirely.'
